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1. Introduction 
Sudden Sensorineural Hearing Loss (SSNHL) is 
typically defined as the acute onset (less than 3 
days) of a perceptive hearing loss of more than 
30dB over at least three contiguous frequencies on 
pure tone  audiometry [1]. The exact incidence of 
SSNHL is uncertain, since many patients have a 
rapid and spontaneous resolution of symptoms and 
therefore don’t reach medical attention. Estimate of 
incidence ranges from 5 to 20 per 100.000 
individuals, and bilateral involvement is very rare 
[2]; it increases in the older patients (>65 yo)(77 per 
100.000) the in younger population (<18 yo)(11 per 
100.000) [3]. The true incidence of paediatric 
SSNHL is not established in literature; 40% of 
examined child with SSNHL, showed anatomic 
abnormalities [4]. 
The left ear is more affected only in female patients; 
the cause is unclear, but this asymmetry might 
indicate a greater vulnerability only in female, due 
to hormonal factors in the genesis of sudden 
deafness [5]. 
The pathogenesis of SSNHL it has been widely 
studied but is not yet entirely clear: it is 
multifactorial, and various causes have been 
proposed, including viral infection of the labyrinth 
or cochlear nerve, autoimmune ear disease, acoustic 
tumors, perilymphatic fistula, intracochlear 
membrane trauma or rupture, drug toxicity, 
vascular disorders (including hemorrhaging, 
thrombosis, embolism, vasospasm and 
hypercoagulability in the microcirculation of the 
cochlea)[6], Meniere’s disease [7](Figure 1); in 
addition, major depression ad anxiety can be the 
cause of sudden deafness [8]. 
However, in most patients the cause is hidiopatic. 
It is commonly presented as a sudden unilateral 
deafness on awakening; aural fullness, tinnitus, 
vertigo and dysequilibrium are present to a variable 
degree in approximately 40% of patients [9].  
The clinician should exclude a conductive haring 
loss, perform an audiometry test as soon as possibile 
(within 14 days of symptoms onset) and evaluate 
the patient for retrocochlear pathology by optioning 
an MRI or auditory brainstem response (ABR); CT 
scan ad routine laboratory tests are not 
recommended in the approach. 
Most recovery occurs within the first 2 weeks after 
onset; without treatment of any kind, a significant 
proportion (30% to 65%) of patients experience 
complete or partial recovery. (Figure 2). 
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Figure 1. Cause of Sudden Sensorineural Hearing Loss (from “Hearing loss in adults: differential diagnosis and 
treatment”, Michels TC et al., Am Fam Physician 2019 Jul 15;100(2):98-108) 
 
Figure 2. Siegel’s criteria: degree of hearing recovery from sudden hearing loss 
 




Treatment of SSNHL should be based on its 
etiology. Most cases are idiopathic; the best options 
is initial therapy with corticosteroids, which can be 
combined with hyperbaric oxygen therapy within 2 
weeks of onset of SSNHL.  
Hyperbaric oxygen therapy (HBO) can be offered 
or combined with steroid therapy within 2 weeks of 
onset of SSHl, or combined with steroid therapy as 
salvage within 1 month of onset of symptoms. Some 
authors [11] recommend the routine application of 
HBO with intravenous steroid for all patients with 
idiopathic sudden sensorineural hearing loss within 
14 days from the onset of symptoms. 
Antivirals, trombolytics and a vasodilatators are not 
recommended.  
When patients have incomplete recovery 2 to 6 
weeks after onset of symptoms, intratympanic 
steroids could be an option as salvage therapy [1]. 
Meniere syndrome can occur in 5% of cases with 
SSNHL; generally, other symptoms are present 
(vertigo, tinnitus)[12,13]. Schaaf et al. [14] reported 
that recurrent low-frequency sensory hearing loss 
Causes of Sudden Sensorineural Hearing Loss 
Type of  
hearing loss   Cause 
 
Idiopathic   Unknown 
 
Infectious   EBV, group A streptococcus, HSV, HZV, HIV,  
    Lyme disease, meningitis, syphilis 
 
Otologic   Autoimmune condition, Meniere disease 
 
Trauma   Barotrauma, ear trauma or head trauma 
 
Vascular   Cerebrovascular disease 
 
Neoplastic   Angioma, hyperviscosity, meningioma, 
    neurofibromatosis 2, schwannoma 
 
Other    Genetic cause, mitochondrial disorder,  
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can be one characteristic of Meniere’s disease; in 
this work, only 3.7% of the patients developed the 
typical signs of Meniere’s disease, and 25.9% of 
these suffered from recurrent hearing loss. They 
conclude that although almost every patient with 
Meniere’s disease suffers from recurrent hearing 
loss, only a few patients with recurrent hearing loss 
develop Meniere’s disease. 
Acute low-tone sensorineural hearing loss 
(ALSHL) is a deterioration in audiometric low 
frequencies (250-500 Hz) with preservation of high 
frequencies; it was initially considered as a variant 
of SSNHL, until it was described as an independent 
disease entity. Moreover, there are several 
differences beetween ALSHL and SSNHL; 1) 
predominance of female (72.9%), 2) more dizzines 
(36%) and tinnitus (42.8%), 3) ear fullness (20.8%), 
4)better prognosis of complete recovery (from 
67.7% to 77%), 5) absence of predictive factors, 6) 
an important develop to Meniere’s disease 15%) 
[15]. 
Additionally, the incidence of relapse is higher than 
in SSNHL (24%) [16,17]. 
 
Although there are many reports about the 
pathogenesis, treatment and prognostic criteria of 
SSNHL, few studies have examined relapsed 
neurosensorial hearing loss.; moreover,  most of the 
studies do not investigate the pathologies leading to 
relapses.  
The aim of this paper is to evaluate the incidence 
and the risk factors of recurrent non-hydropic 
SSNHL in literature.  
 
2. Discussion 
We define SSNHL relapse as an episode of SSNHL 
greater than or equal than the first episode of 
SSNHL; it consists in two types, ipsilateral and 
controlateral SSNHL; the ipsilateral type is defined 
as the first episode of idiopathic sudden deafness 
that had hearing improvement; after a period, a 
second episode of sudden deafness recurred in the 
same ear. In the contralateral type, two episodes of 
sudden deafness occurred in each ear, alternatively 
[18]. Kuo YL et al. comparised the two types, and 
no significant differences existed in term of 1) age 
of onset at the second episode, 2) gender, 3) 
laterality, 4) presence of vertigo, 5) spontaneous 
nystagmus, 6) abnormal ENG findings, 7) abnormal 
caloric results, 8) initial and final mean hearing. A 
significant difference was observed in abnormal 
VEMPs between the two types; all patients with 
ipsilateral type had normal VEMPs associated with 
improved hearing, whereas all patients with 
contralateral type showed abnormal VEMPs. In 
conclusion, the demonstration of normal VEMPs in 
the lesion ear of the second wayside in patients with 
recurrent SSNHL may indicate a good hearing 
outcome. 
The main cause (90%) of SSNHL is idiopathic 
sudden sensorineural hearing loss (ISSNHL) in 
which the cause is not identifiable (o 
undetermined); is commonly unilateral, and 
bilateral loss should lead thinking about other 
causes. It is not commonly associated with other 
symptoms. 
The incidence of ISSNHL relapse reported in the 
English Literature varie from 0.8% [19] to 8.3% 
[20].  
The definite pathogenesis of ISSNHL is currently 
unclear 
Che-Ming Wu et. al [21] described one of the 
largest cohort of patients with ISSNHL; a relapse od 
ISSNHL occurred in 2.281 patients (incidence 
4.99%). The relapse was significantly higher (60%) 
in middle age patients (35-64 yo) than in younger 
patients (0-34 yo) (17%). In this study there is an 
higher prevalence of comorbid diabetes mellitus 
and hypercholesterolemia in the patients with a 
recurrence of ISSNHL than in those without, 
suggesting that the insufficient cochlear perfusion is 
an important risk factor for the recurrence of sudden 
deafness; otherwise, the individual comorbidities of 
coronary artery disesase, hypertension, chronic 
renal disease, diabetes mellitus and 
hypercholesterolemia are not associates with an 
higher incidence of ISSNHL. There is no a large 
difference in relapse between male and female 
(54.11% vs. 45.89%). 
Identifiable causes are found for 7% to 45% of 
patients with SSNHL [22, 23, 24].  
The ethiology is very broad; Chau et al. [25], 
identified infections (13%), otologic problems 
(5%), traumatic (4%), vascular (3%), neoplastic 
(2%) as the most frequent cause of symptomatic 
sudden hearing loss. Capuano et al [26] suggested 
that patent forman ovale and right to left shunt are 
frequent in ISSNHL, particularly in young patients 
without comorbidities and with associated 
dizziness. 
Infectious, traumatic, metabolic and neurologic 
disease are not linked to relapsed SSNHL (although 
increased levels of neutrophil to lymphocyte ratio 
(NLR) e platelet to lymphocyte ratio (PLR) have 
been shown in relapse SSNHL [27]. About 
infections in recurrent SSNHL, some authors [28] 
speculate that are caused by a reactivation of a latent 
HSV infection; in some patient, high values of 
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serum antibody titer for adenovirus 3 or human 
HSV-1 or VZV were detected. 
Some vascular diseases can cause recurrent 
SSNHL, usually associated with other symptoms. 
Lee and Cho [29] proposed some auditory 
disturbance (as recurrent sudden sensorineural 
hearing loss) as a warning sing of impeding 
pontocerebellar infarction in the distribution of 
anterior inferior cerebellar artery (AICA) due to the 
ischemia of the inner ear or the vestibulocochlear 
nerve. In the opinion of Park JH et al. [30], in 
elderly patients (expecially with particular risk 
factors) with recurrence of hearing loss and vertigo 
lasting several minutes, physicians may also 
consider the potential symptom of AICA infarction. 
Park H et. al [31] reported a single case of unilateral 
recurrent hearing loss due to medullary infarction. 
Bliss et al. [32] described an interesting report about 
recurrent contralateral hearing loss after two 
craniotomies for vestibular schwannoma; SSNHL 
on the the side opposite cerebellopontine angle 
surgery is a rare but well-documented occurrence. 
Most losses are recurrent but transient; the cause for 
the contralateral loss is still unclear; auto-immune 
mediated cocheolabyrinthitis [33], cardiovascular 
complication [34], allergy [35], labyrinthine rupture 
from elevated intratympanic pressure during 
general anestethic [36] are just theories. 
Some authors, as Walsted et al. [37] proposed the 
concept of a relative endolymphatic hydrops in the 
controlateral ear after vestibular schwannoma 
removed; they suggested that low CSF pressure can 
be transmitted to the cochlea through the cochlear 
aqueduct, creating a low pelymphatic pressure. 
Some neoplasm may be related to recurrent 
SSNHL; for example, a vestibular schwannoma or 
another tumor in the internal auditory canal or at the 
cerebellopontine angle should be the cause [7].  
MRI imaging should be performed to evaluate a 
vascular or retrocochlear pathology. 
Electrocochleographic findgs should be assessed as 
prognostic factors in ISSNHL; in a study by Ohashi 
et al. [38], the patients were examined with 
transtympanic trasnpromontory ECochG within 5 
days from the onset of symptoms; they concluded 
that an enhanced SP/AP ratio and a low initial AP 
threshold may be positive prognostic factors in 
recurrent ISSNHL; furthermore the presence of 
initial vertigo seems to be an unfavourable factor in 
recurrent ISSNHL. 
Prognosis and recurrence rate can be influenced by 
many factors; metabolic syndrome [39], 
hyperlipidemia [40], diabetes mellitus 
[41,42,43,44,45] are negative prognostic factors for 
recovery and recurrences; furthermore, hearing 
recovery is poorer after a second attack of SSNHL. 
 
3. Conclusion 
Although recurrent non-hydropic SSNHL is 
unfrequent, it represents a diagnostic and 
therapeutic challenge.  
Differential diagnosis is essential to distinguish 
idiopathic forms from those symptomatic: the 
clinician should pay attention to vascular disease 
and retrocochlear neoplasm. 
The literature established that recurrent SSNHL has 
a poorer prognosis than a single episode of sudden 
hearing loss.  
Although some factors are described to affect 
recovery and recurrent state, further studies should 
needed to explain better the related mechanisms and 
to evaluate the role of audiometric examinations. 
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